Mint BioTech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $28.3M

  • Investors
  • 8

Mint BioTech General Information

Description

Developer and operator of a synthetic biology technology platform designed to improve the quality of life with biotechnology. The company's platform designs and develops environmentally friendly, economical and efficient intelligent biomolecules and materials, enabling industry users to improve productivity and sustainability with innovative biotechnology.

Contact Information

Website
www.mint-bio.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 303-1, Lufang Kechuang Building, No. 1, Xiyuan 7th Road
  • Xihu District
  • Hangzhou, Zhejiang 310000
  • China
+86 0751
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 303-1, Lufang Kechuang Building, No. 1, Xiyuan 7th Road
  • Xihu District
  • Hangzhou, Zhejiang 310000
  • China
+86 0751

Mint BioTech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mint BioTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 22-Oct-2024 $28.3M Completed Generating Revenue
4. Early Stage VC 14-Aug-2023 Completed Generating Revenue
3. Early Stage VC 11-Nov-2022 Completed Generating Revenue
2. Early Stage VC 15-Mar-2022 $15.6M Completed Generating Revenue
1. Seed Round 01-Dec-2021 $15.6M $15.6M Completed Startup
To view Mint BioTech’s complete valuation and funding history, request access »

Mint BioTech Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Mint BioTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4174185-A1 Methods for preparing pantoic acid, pantothenic acid and panthenol as well as salts thereof Pending 28-Jun-2020
US-20230348941-A1 Methods for preparing pantoic acid, pantothenic acid and panthenol as well as salts thereof Active 28-Jun-2020

Mint BioTech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Merchants Venture Capital Corporate Venture Capital Minority
Hangzhou Chengtou Venture Capital Minority
Xihu VC Government Minority
SenseTime Corporation Minority
Westlake Education Foundation Not-For-Profit Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Mint BioTech FAQs

  • When was Mint BioTech founded?

    Mint BioTech was founded in 2021.

  • Where is Mint BioTech headquartered?

    Mint BioTech is headquartered in Hangzhou, China.

  • What industry is Mint BioTech in?

    Mint BioTech’s primary industry is Biotechnology.

  • Is Mint BioTech a private or public company?

    Mint BioTech is a Private company.

  • What is Mint BioTech’s current revenue?

    The current revenue for Mint BioTech is .

  • How much funding has Mint BioTech raised over time?

    Mint BioTech has raised $44M.

  • Who are Mint BioTech’s investors?

    China Merchants Venture Capital, Hangzhou Chengtou, Xihu VC, SenseTime, and Westlake Education Foundation are 5 of 8 investors who have invested in Mint BioTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process